JDOCvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with JDOC, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
JDOC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | JDOC ETF 2 | +1.71%– | +10.10%– | +5.87%– | +23.40%– | n/a– | n/a– |
| Flows | JDOC ETF 2 | -– | -$3M– | -$34K– | -$34K– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | JDOC ETF 2 | +17.44%– | +15.07%– | n/a– | n/a– |
| Max drawdown | JDOC ETF 2 | -3.99%– | -9.66%– | n/a– | n/a– |
| Max drawdown duration | JDOC ETF 2 | 22d– | 154d– | n/a– | n/a– |
Trading data
JDOC | ETF 2 | |
Last sale 7/31/2026 at 1:30 PM | $60.64 | – |
| Previous close 07/30/2026 | $61.37 | – |
| Consolidated volume 07/30/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
JDOC | ETF 2 | |
|---|---|---|
| Last price | $60.64 | – |
| 1D performance | -1.19% | – |
| AuM | $9.19 M | – |
| E/R | 0.65% | – |
Characteristics
JDOC | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | J.P. Morgan Asset Management | – |
| Benchmark | - | – |
| N° of holdings | 61 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 1, 2023 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
JDOC
USA
75.5%
Other
24.5%
ETF 2
Sectors
JDOC
Healthcare
96.8%
Other
3.2%
ETF 2
Advertisement
Diversification
JDOC
Total weight of top 15 holdings out of 15
60.84%
ETF 2
–
Top 15 holdings
Data as of June 30, 2026
JDOC
Eli Lilly & Co.
7.79%
AbbVie, Inc.
7.78%
UnitedHealth Group, Inc.
6.36%
Johnson & Johnson
4.83%
Merck & Co., Inc.
4.75%
AstraZeneca PLC
4.18%
Thermo Fisher Scientific, Inc.
3.36%
CVS Health Corp.
3.20%
Bristol Myers Squibb Co.
3.10%
Abbott Laboratories
2.81%
Roche Holding AG
2.73%
Novo Nordisk A/S
2.69%
GSK Plc
2.52%
argenx SE
2.50%
Intuitive Surgical, Inc.
2.24%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
